Wednesday 27th November 9:30 am - 12:30 pm
Novel Immunotherapies for Solid Tumours
Virtual delivery via MS Teams
This 3-hour virtual course emphasises the progress made in developing novel immunotherapies for solid tumours, such as CAR T cell therapy, TCR-engineered T cell therapy, tumour infiltrating lymphocytes, T cell engagers, and vaccine-based treatments.